Skip to main content

Table 1 GlpQ serology kinetics for the 14/138 patients with a serological follow-up, who had at least one positive (ELISA + WB) test and their doxycycline treatment status after the acute blood sampling

From: Assessment of Borrelia miyamotoi in febrile patients and ticks in Alsace, an endemic area for Lyme borreliosis in France

Patient

Age (years)

Time between symptom onset and acute sampling (day)

Time between symptom onset and convalescence sampling (days)

Time between the two samples (days)

Tick bite

Serological results

Doxycycline administration after the acute sampling

Final diagnosis retained by physician

Acute sample IgM

Acute sample IgG

Convalescence sample IgM

Convalescence sample IgG

A

65

17

63

46

Yes

Neg

Neg

Pos

Pos

Yes

HGA

B

37

8

42

34

No

Pos

Neg

Neg

Neg

Yes

Malaria

C

67

14

56

42

Yes

Pos

Neg

Neg

Neg

Yes

HGA

D

83

9

42

33

Yes

Pos

Neg

Neg

Neg

Yes

HGA

E

44

4

56

52

Yes

Neg

Neg

Pos

Neg

Yes

No

F

62

Unknown

Unknown

82

Unknown

Neg

Pos

Neg

Pos

Unknown

Unknown

G

49

16

56

40

Yes

Neg

Neg

Pos

Neg

Yes

No

H

53

Unknown

Unknown

50

Unknown

Neg

Neg

Pos

Neg

Unknown

Unknown

I

38

Unknown

Unknown

50

Unknown

Neg

Neg

Pos

Neg

Unknown

Unknown

J

42

Unknown

Unknown

40

Unknown

Pos

Neg

Neg

Neg

Unknown

Unknown

K

71

18

79

61

No

Pos

Neg

Pos

Neg

Yes

CMV infection

L

53

19

56

37

No

Pos

Neg

Neg

Neg

No

EBV infection

M

28

17

70

53

No

Pos

Neg

Neg

Neg

No

CMV+EBV infection

N

39

5

49

44

Yes

Neg

Neg

Pos

Neg

No

No

  1. Abbreviations: HGA, human granulocytic anaplasmosis; EBV, Epstein-Barr virus; CMV, cytomegalovirus; Pos, positive; Neg, negative; No, no final diagnosis retained at time of consultation